Wedbush analyst Richard Anderson raised the firm’s price target on Welltower to $169 from $167 and keeps an Outperform rating on the shares. While Ventas (VTR) and Welltower (WELL) own an otherwise diversified collection of health care property types, senior housing operating is by far the key to stock performance in both cases. Earnings for Q1 did not disappoint, Wedbush adds.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WELL:
- Welltower Inc. Reports Strong Q1 2025 Earnings
- Welltower, Inc. Reports Strong Earnings and Optimistic Outlook
- Welltower reports Q1 normalized FFO $1.20, consensus $1.15
- Welltower raises 2025 FFO view to $4.90-$5.04 from $4.79-$4.95, consensus $4.95
- Welltower options imply 3.2% move in share price post-earnings